{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-091194","form_type":"8-K","ticker":"NTRA","cik":"0001604821","company_name":"Natera, Inc.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.338214+00:00","generated_at":"2026-06-23T23:51:56.599406+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Monica Bertagnolli resigns from Natera board to lead National Cancer Institute","bullets":["Monica Bertagnolli resigned from the Board and all committees effective August 12, 2022.","Resignation due to her appointment as Director of the National Cancer Institute.","Not related to any disagreement with Natera's operations, policies, or practices.","No replacement director has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-091194","json":"https://secwatch.observer/filing/0001104659-22-091194.json","markdown":"https://secwatch.observer/filing/0001104659-22-091194.md","text":"https://secwatch.observer/filing/0001104659-22-091194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604821/000110465922091194/0001104659-22-091194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604821/000110465922091194/tm2223160d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:51:56.599406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51bbf9fa2f","claim":"Monica Bertagnolli resigned as Director at Natera, Inc..","evidence_excerpt":"On August 11, 2022, Monica Bertagnolli notified the Board of Directors (the “Board”) of Natera, Inc. (“Natera” or the “Company”) of her intention to resign as a member of the Board and any committees of the Board, effective August 12, 2022, in connection with her appointment as Director of the National Cancer Institute.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604821/000110465922091194/0001104659-22-091194-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}